Many studies of cryptococcosis prevention exclusively focus on ART-naïve populations, but our finding that two (25%) of those with cryptococcal antigenaemia were ART-experienced suggests that CrAg screening should not be restricted to newly diagnosed HIV. The gene discussed is AGAP3; the disease is cryptococcosis.